Tumor cell killing by the AF Irofulven depends on the status of BRCA1/2 and Fanconi anemia proteins (FANCD2), which are involved in homology-directed repair of DSBs with Irofulven-induced DSB being considered a replication-associated DNA damage event (21). Here, BRCA1 is linked to neoplasm.